Cutler Group LP Seres Therapeutics, Inc. Put Options Transaction History

Cutler Group LP

6 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2023 Nov 07, 2023	BUY	$2.33 - $5.07 $9,320 - $20,280	4,000 Added 160.0%	6,500 $17,000
Q2 2023 Jul 18, 2023	BUY	$4.67 - $6.55 $11,675 - $16,375	2,500 New	2,500 $2,000
Q3 2021 Oct 26, 2021	BUY	$5.46 - $22.6 $19,656 - $81,360	3,600 Added 225.0%	5,200 $2,000
Q4 2020 Jan 21, 2021	SELL	$23.25 - $37.73 $67,425 - $109,416	-2,900 Reduced 64.44%	1,600 $0
Q3 2020 Oct 27, 2020	BUY	$3.74 - $28.74 $13,090 - $100,590	3,500 Added 350.0%	4,500 $0
Q4 2017 Jan 17, 2018	BUY	$9.15 - $12.64 $9,150 - $12,640	1,000	1,000 $3,000

46.7M

119K

466K

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $102M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.